Slinda contraceptive pill

Slinda is a progestogen-only contraceptive pill (POP) containing drospirenone. It was developed by the Spanish pharmaceutical group Exeltis, which is part of the Insud Pharma family. The brand is known for offering an alternative to combined contraceptive pills, particularly for women who are estrogen-sensitive or breastfeeding.

Manufacturing generally takes place in specialized pharmaceutical facilities in Europe, specifically Spain and France, where Insud Pharma maintains significant industrial operations. Because the brand is marketed globally, distribution is often handled by various regional partners or local subsidiaries under the Exeltis umbrella. The ownership remains firmly with the Spanish multinational Insud Pharma, ensuring consistent quality and global reach.